395 related articles for article (PubMed ID: 32698830)
1. Vestibular prognosis in idiopathic sudden sensorineural hearing loss with vestibular dysfunction treated with oral or intratympanic glucocorticoids: a protocol for randomized controlled trial.
Hao W; Zhao L; Yu H; Li H
Trials; 2020 Jul; 21(1):669. PubMed ID: 32698830
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of vestibular dysfunction in idiopathic sudden sensorineural hearing loss with vertigo: a prospective cohort study.
Hao W; Ye L; Yu H; Li H
J Neurol; 2023 Nov; 270(11):5516-5526. PubMed ID: 37517037
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic methylprednisolone administration promotes the recovery of idiopathic sudden sensorineural hearing loss: a retrospective case-control study.
Jiang K; Li S; Cheng L; Yang J
Acta Otolaryngol; 2018 Nov; 138(11):998-1003. PubMed ID: 30465620
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of high dose systemic versus combined (systemic and intratympanic) corticosteroid therapy in idiopathic sudden sensorineural hearing loss: A prospective randomized trial and risk factor analysis.
Kovács M; Uzsaly J; Bodzai G; Pap I; Lippai B; Dergez T; Németh A; Gerlinger I; Szanyi I; Bakó P
Am J Otolaryngol; 2024; 45(1):104099. PubMed ID: 37948820
[TBL] [Abstract][Full Text] [Related]
5. Assessment of balance and vestibular functions in patients with idiopathic sudden sensorineural hearing loss.
Liu J; Zhou RH; Liu B; Leng YM; Liu JJ; Liu DD; Zhang SL; Kong WJ
J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):264-270. PubMed ID: 28397037
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in elderly patients after an intra-tympanic steroid injection for idiopathic sudden sensorineural hearing loss.
Chen SL; Hu CY; Chan KC; Chin SC; Ho CY
Am J Otolaryngol; 2022; 43(5):103528. PubMed ID: 35691052
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss in children.
Chung JH; Cho SH; Jeong JH; Park CW; Lee SH
Laryngoscope; 2015 Sep; 125(9):2209-15. PubMed ID: 25689850
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Intratympanic Glucocorticoid Steroid Administration Therapy as an Initial Treatment for Idiopathic Sudden Sensorineural Hearing Loss During the COVID-19 Pandemic.
Tsuda T; Hanada Y; Wada K; Fujiwara E; Takeda K; Nishimura H
Ear Nose Throat J; 2023 Dec; 102(12):772-779. PubMed ID: 34247535
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.
Gouveris H; Schuler-Schmidt W; Mewes T; Mann W
Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933
[TBL] [Abstract][Full Text] [Related]
10. Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial.
Yang W; Li X; Zhong J; Mei X; Liu H; Yang L; Lu L; Hu H
Trials; 2020 Feb; 21(1):135. PubMed ID: 32014060
[TBL] [Abstract][Full Text] [Related]
11. Discriminant Analysis of the Prognostic Factors for Hearing Outcomes in Patients with Idiopathic Sudden Sensorineural Hearing Loss.
Askar AA; Ghonim MR; Shabana YK
J Int Adv Otol; 2023 Jun; 19(3):162-168. PubMed ID: 37272631
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life and Hearing Eight Years After Sudden Sensorineural Hearing Loss.
Härkönen K; Kivekäs I; Rautiainen M; Kotti V; Vasama JP
Laryngoscope; 2017 Apr; 127(4):927-931. PubMed ID: 27328455
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Two Different Treatment Protocols Using Systemic and Intratympanic Steroids with and without Hyperbaric Oxygen Therapy in Patients with Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss: A Randomized Controlled Trial.
Cho I; Lee HM; Choi SW; Kong SK; Lee IW; Goh EK; Oh SJ
Audiol Neurootol; 2018; 23(4):199-207. PubMed ID: 30380530
[TBL] [Abstract][Full Text] [Related]
14. The value of having an initial word recognition score for a precise prognosis of idiopathic sudden sensorineural hearing loss.
Kwak C; Seo YJ; Yoon C; Lee J; Han W
Auris Nasus Larynx; 2022 Aug; 49(4):554-563. PubMed ID: 34772562
[TBL] [Abstract][Full Text] [Related]
15. Acupuncture as an early treatment for idiopathic sudden sensorineural hearing loss (ISSNHL) patients with flat or high-frequency drop audiograms: study protocol for a randomized controlled trial.
Shang K; Ma X; Liu HL; Jing YY; Zeng L; Li N; Zhou DA; Wei J; Zhang C
Trials; 2018 Jul; 19(1):356. PubMed ID: 29973265
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Galvanic Vestibular-evoked Myogenic Potentials and the Prognosis of Unilateral Severe to Profound Idiopathic Sudden Sensorineural Hearing Loss With Vertigo.
Chang CM; Lo WC; Young YH; Liao LJ; Cheng PW
Otol Neurotol; 2021 Aug; 42(7):e858-e865. PubMed ID: 34260506
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.
Suzuki H; Wakasugi T; Kitamura T; Koizumi H; Do BH; Ohbuchi T
Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):235-240. PubMed ID: 29411622
[TBL] [Abstract][Full Text] [Related]
18. Intratympanic dexamethasone for managing pregnant women with sudden hearing loss.
Fu Y; Jing J; Ren T; Zhao H
J Int Med Res; 2019 Jan; 47(1):377-382. PubMed ID: 30328358
[TBL] [Abstract][Full Text] [Related]
19. Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: Meta-analysis of randomized controlled trials.
Lai D; Zhao F; Jalal N; Zheng Y
Medicine (Baltimore); 2017 Dec; 96(50):e8955. PubMed ID: 29390288
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial.
Filipo R; Attanasio G; Russo FY; Viccaro M; Mancini P; Covelli E
Laryngoscope; 2013 Mar; 123(3):774-8. PubMed ID: 23378346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
